Delivery Order SPE2DR25D2209-SPE2DR26FD6QC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,532.88 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 26, 2025, with an ultimate completion date of November 28, 2025. This competitive, non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $1,652.29. The contract, awarded on December 23, 2025, with an ultimate completion date of December 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $5,796.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1,000 mg/10 mL vials on November 14, 2025, with completion expected by November 17, 2025. Procainamide is an antiarrhythmic medication used to treat cardiac arrhythmias, and this competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,444.77 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Procainamide 1,000 mg/10 mL vials (10 mL quantity). This firm fixed price contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 29, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used to treat cardiac arrhythmias and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $2,172.15. This award, issued on December 31, 2025, with an ultimate completion date of January 2, 2026, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $5,005.35. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procurement. The product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $13,436.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/2 mL vials on September 25, 2025, with completion scheduled for September 26, 2025. This non-competitive, non-set-aside award is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Department's Medical Supply Chain for one gram per 10 milliliter vials of Procainamide, a cardiac antiarrhythmic medication. The May 30, 2025 award, valued at $1,562.92 with completion scheduled for June 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,137.63. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2209Indefinite Delivery Contract
- SPE2DR25D2209-SPE2DR26FD6QCDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,048.68 for Procainamide 1 gram/10 milliliter vials on January 2, 2026, with completion scheduled for January 5, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Procainamide is a cardiac antiarrhythmic medication used to treat abnormal heart rhythms and is essential for military medical supply chains supporting defense healthcare operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide through this prime contract vehicle. The company's competitively awarded federal contracts demonstrate its capability to fulfill diverse medical supply requirements across multiple therapeutic domains for defense and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 1/1/26 |